Herbalife (HLF) 주식 개요
는 자회사와 함께 북미, 멕시코, 중남미, 유럽, 중동, 아프리카, 중국 및 아시아 태평양 지역에서 건강 및 웰니스 제품을 제공하고 있습니다. 자세히 보기
HLF Community Fair Values
Create NarrativeSee what 27 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Herbalife Ltd. 경쟁사
가격 이력 및 성과
| 과거 주가 | |
|---|---|
| 현재 주가 | US$15.98 |
| 52주 최고가 | US$20.40 |
| 52주 최저가 | US$6.45 |
| 베타 | 0.96 |
| 1개월 변동 | 10.90% |
| 3개월 변동 | -5.89% |
| 1년 변동 | 121.94% |
| 3년 변동 | 16.30% |
| 5년 변동 | -66.34% |
| IPO 이후 변동 | 334.24% |
최근 뉴스 및 업데이트
HLF: 2026 Guidance And Margin Recovery Will Drive Turnaround Momentum
Analysts lifted their price targets for Herbalife by as much as $4, with some pointing to Q4 results that were largely in line, fresh 2026 guidance, and what they view as stronger recent momentum as key factors behind the adjustment. Analyst Commentary Bullish analysts are highlighting recent price target increases on Herbalife as a sign of improving confidence in the story, especially after Q4 results that were described as largely in line and supported by new 2026 guidance.
HLF: Turnaround Momentum And Q1 2026 Outlook Will Support Margin Recovery
Herbalife's updated analyst price target has moved from $14.00 to $16.50 as analysts factor in recent target increases, slightly higher projected revenue growth and margins, and a modestly lower discount rate, alongside updated views on valuation multiples. Analyst Commentary Recent research views on Herbalife show a mix of optimism about a potential turnaround and caution about the broader sector and the company’s fundamentals.
HLF: 2026 Turnaround Ambitions Will Face Ongoing Competitive And Fundamental Pressures
Herbalife's analyst price target has shifted toward $9.00, with recent research citing Q4 results viewed as solid by some firms, new 2026 guidance, and mixed views on valuation and competitive pressures. Some analysts also commented that regulatory concerns in the U.S. are considered resolved and the business model more sustainable.Recent updates
HLF: 2026 Guidance And Margin Recovery Will Drive Turnaround Momentum
Analysts lifted their price targets for Herbalife by as much as $4, with some pointing to Q4 results that were largely in line, fresh 2026 guidance, and what they view as stronger recent momentum as key factors behind the adjustment. Analyst Commentary Bullish analysts are highlighting recent price target increases on Herbalife as a sign of improving confidence in the story, especially after Q4 results that were described as largely in line and supported by new 2026 guidance.HLF: Turnaround Momentum And Q1 2026 Outlook Will Support Margin Recovery
Herbalife's updated analyst price target has moved from $14.00 to $16.50 as analysts factor in recent target increases, slightly higher projected revenue growth and margins, and a modestly lower discount rate, alongside updated views on valuation multiples. Analyst Commentary Recent research views on Herbalife show a mix of optimism about a potential turnaround and caution about the broader sector and the company’s fundamentals.HLF: 2026 Turnaround Ambitions Will Face Ongoing Competitive And Fundamental Pressures
Herbalife's analyst price target has shifted toward $9.00, with recent research citing Q4 results viewed as solid by some firms, new 2026 guidance, and mixed views on valuation and competitive pressures. Some analysts also commented that regulatory concerns in the U.S. are considered resolved and the business model more sustainable.HLF: 2026 Turnaround Hopes Will Confront Persistent Competitive And Fundamental Risks
The analyst price target for Herbalife has been raised by $1 to $9. Analysts point to largely in line Q4 results, new 2026 guidance, and a mix of Buy, Neutral, and Underperform views that reflect both perceived momentum and ongoing concerns around competition, fundamentals, and valuation.HLF: Turnaround Will Be Driven By 2026 Guidance And Margin Recovery
Narrative Update: Herbalife The updated analyst fair value estimate for Herbalife has moved from $11 to $25, a shift analysts link to refreshed price targets in the $9 to $21 range, stronger Q4 commentary, improved margin assumptions, and a lower discount rate despite mixed views on long term growth and valuation risks. Analyst Commentary Recent Street research on Herbalife reflects a mix of views, but several bullish analysts have been willing to raise price targets or upgrade their stance following recent updates from the company.Herbalife's Turnaround Accelerates With Ronaldo's Pro2col
Feb 22HLF: Turnaround Hopes Under New Leadership Will Confront Compressed Sector Multiples
Narrative Update: Herbalife Analyst Price Target Move The blended analyst price target for Herbalife has moved higher, with recent increases such as Mizuho's lift to $13 and Maxim's initiation at $20. Analysts point to an ongoing turnaround, progress under new leadership, and a healthier long term profile for Herbalife's business model, while also noting continuing concerns about competition and broader macro uncertainty.HLF: Recovery Story Under New Leadership Will Face Compressed Sector Multiples
Narrative Update on Herbalife The analyst price target for Herbalife has been revised higher to reflect an updated fair value of $8.00, a lower discount rate of 10.02%, and adjustments to revenue growth, profit margin, and future P/E assumptions, as analysts factor in recent target hikes, Buy initiations, and views of a continuing recovery path under new leadership. Analyst Commentary Recent Street research on Herbalife reflects a mix of optimism about a potential recovery and caution around execution and valuation risks.Herbalife Ltd. (NYSE:HLF) Shares Fly 27% But Investors Aren't Buying For Growth
Jan 22
HLF: Turnaround And Margin Recovery Under New Leadership Will Face Valuation Constraints
The analyst price target on Herbalife in our model has moved from US$12 to US$14, as analysts point to a recovery path supported by a healthier profit margin outlook, a slightly lower discount rate, and recent research highlighting ongoing business model improvements despite tempered revenue growth expectations and cautious sector valuations. Analyst Commentary Recent research on Herbalife reflects a mix of optimism about the company’s turnaround efforts and caution about broader sector and macro headwinds.HLF: Recovery Path Under New Leadership Will Likely Deliver Disappointing Multiple Expansion
Analysts have modestly raised their fair value estimate for Herbalife from approximately $9.67 to $12.00 per share, citing a lower perceived risk profile, steady growth and margin assumptions, and a more constructive view on future earnings multiples as fundamentals continue on a recovery path under new leadership. Analyst Commentary Analyst sentiment around Herbalife is gradually improving as execution under new leadership gains traction and forward growth expectations firm up, though views on the pace and durability of the recovery remain mixed.HLF: Recovery Path Under New Leadership Will Likely Prove Overpriced
Analysts have modestly raised their price target on Herbalife to $11 from $10, citing a gradually lower perceived risk profile, steady long term growth and margin assumptions, and growing confidence that the company is on a recovery path under new leadership, with a potential return to volume growth by fiscal 2026. Analyst Commentary Bullish analysts point to the recent rating upgrade and price target increase as evidence that sentiment around Herbalife is gradually improving, with expectations that operational execution will support a more favorable risk and reward profile over the next several years.HLF: Uncertainty Around CEO Transition Will Challenge Near-Term Momentum
Herbalife’s analyst price target has been raised to $11 from $10, as analysts point to recovering fundamentals and the company’s strategic leadership changes as promising signs for future growth. Analyst Commentary Analysts have recently weighed in on Herbalife, offering a mix of optimism about its improving fundamentals and some caution about ongoing risks.We Think That There Are Some Issues For Herbalife (NYSE:HLF) Beyond Its Promising Earnings
Nov 13The Market Doesn't Like What It Sees From Herbalife Ltd.'s (NYSE:HLF) Earnings Yet
Oct 29At US$8.75, Is Herbalife Ltd. (NYSE:HLF) Worth Looking At Closely?
Sep 26A Look At The Intrinsic Value Of Herbalife Ltd. (NYSE:HLF)
Jul 24There's No Escaping Herbalife Ltd.'s (NYSE:HLF) Muted Earnings Despite A 26% Share Price Rise
Jun 25Herbalife (NYSE:HLF) Hasn't Managed To Accelerate Its Returns
May 28Herbalife's (NYSE:HLF) Earnings Offer More Than Meets The Eye
May 08Herbalife Ltd.'s (NYSE:HLF) Share Price Boosted 63% But Its Business Prospects Need A Lift Too
Mar 13Herbalife: The Battleground Stock Is Showing Some Turnaround Potential
Feb 24Is It Time To Consider Buying Herbalife Ltd. (NYSE:HLF)?
Feb 19Returns At Herbalife (NYSE:HLF) Appear To Be Weighed Down
Jan 29Herbalife: Down In The Dumps, But Maybe Worth Exploring
Jan 21Investors Still Aren't Entirely Convinced By Herbalife Ltd.'s (NYSE:HLF) Earnings Despite 27% Price Jump
Nov 12We Think You Can Look Beyond Herbalife's (NYSE:HLF) Lackluster Earnings
Nov 06Herbalife: A Top Short Squeeze Idea, Turning Higher In Price
Nov 05What Does Herbalife Ltd.'s (NYSE:HLF) Share Price Indicate?
Nov 01Herbalife: The Biggest Value Trap Of The Moment
Oct 03Herbalife (NYSE:HLF) May Have Issues Allocating Its Capital
Oct 02
Revitalizing Sales Through Innovative Distributor Engagement And Digital Transformation Initiatives
Herbalife's focus on distributor engagement and digital transformation aims to reverse recruitment decline and enhance sales efficiency, potentially boosting revenue.Herbalife Ltd. (NYSE:HLF) Stock's 29% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Aug 14주주 수익률
| HLF | US Personal Products | US 시장 | |
|---|---|---|---|
| 7D | -3.2% | -1.2% | -0.2% |
| 1Y | 121.9% | -16.2% | 27.6% |
수익률 대 산업: HLF은 지난 1년 동안 -16.2%의 수익을 기록한 US Personal Products 산업보다 더 좋은 성과를 냈습니다.
수익률 대 시장: HLF은 지난 1년 동안 27.6%를 기록한 US 시장보다 더 좋은 성과를 냈습니다.
주가 변동성
| HLF volatility | |
|---|---|
| HLF Average Weekly Movement | 8.6% |
| Personal Products Industry Average Movement | 9.1% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.3% |
안정적인 주가: HLF는 지난 3개월 동안 US 시장에 비해 주가 변동성이 크지 않았습니다.
시간에 따른 변동성: HLF의 주간 변동성(9%)은 지난 1년 동안 안정적이었습니다.
회사 소개
| 설립 | 직원 수 | CEO | 웹사이트 |
|---|---|---|---|
| 1980 | 8,500 | Stephan Gratziani | www.herbalife.com |
는 자회사와 함께 북미, 멕시코, 중남미, 유럽, 중동, 아프리카, 중국 및 아시아 태평양 지역에서 건강 및 웰니스 제품을 제공합니다. 식사 대용, 단백질 쉐이크, 음료 믹스, 체중 감량 보조제, 건강 간식, 신진대사 촉진 차 등 체중 관리 제품, 허브, 비타민, 미네랄 및 기타 천연 성분이 함유된 기능성 음료와 식이 및 영양 보충제로 구성된 표적 영양 제품, 에너지, 스포츠 및 피트니스 제품, 페이셜 스킨 케어, 바디 케어, 헤어 케어 제품 등을 제공합니다. 또한 창업 키트, 판매 도구, 교육 자료와 같은 홍보 및 기타 자료도 제공합니다.
Herbalife Ltd. 기초 지표 요약
| HLF 기초 통계 | |
|---|---|
| 시가총액 | US$1.72b |
| 순이익 (TTM) | US$228.30m |
| 매출 (TTM) | US$5.04b |
7.2x
주가수익비율(P/E)0.3x
주가매출비율(P/S)HLF는 고평가되어 있습니까?
공정 가치 및 평가 분석 보기순이익 및 매출
| HLF 손익계산서 (TTM) | |
|---|---|
| 매출 | US$5.04b |
| 매출원가 | US$1.11b |
| 총이익 | US$3.92b |
| 기타 비용 | US$3.69b |
| 순이익 | US$228.30m |
최근 보고된 실적
Dec 31, 2025
다음 실적 발표일
May 06, 2026
| 주당순이익(EPS) | 2.21 |
| 총이익률 | 77.87% |
| 순이익률 | 4.53% |
| 부채/자본 비율 | -390.7% |
HLF의 장기 실적은 어땠습니까?
과거 실적 및 비교 보기기업 분석 및 재무 데이터 상태
| 데이터 | 최종 업데이트 (UTC 시간) |
|---|---|
| 기업 분석 | 2026/04/29 13:01 |
| 종가 | 2026/04/29 00:00 |
| 수익 | 2025/12/31 |
| 연간 수익 | 2025/12/31 |
데이터 소스
당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.
| 패키지 | 데이터 | 기간 | 미국 소스 예시 * |
|---|---|---|---|
| 기업 재무제표 | 10년 |
| |
| 분석가 컨센서스 추정치 | +3년 |
|
|
| 시장 가격 | 30년 |
| |
| 지분 구조 | 10년 |
| |
| 경영진 | 10년 |
| |
| 주요 개발 | 10년 |
|
* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.
별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.
분석 모델 및 스노우플레이크
이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.
Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.
산업 및 섹터 지표
산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.
분석가 소스
Herbalife Ltd.는 15명의 분석가가 다루고 있습니다. 이 중 4명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
| 분석가 | 기관 |
|---|---|
| John Staszak | Argus Research Company |
| Meredith Adler | Barclays |
| Brian Wang | Barclays |